January 22, 2018

Movement Biomarker Could Help In Autism Diagnosis

Article origination IPBS-RJC
Indiana University graduate student Di Wu observes a test subject. - Photo courtesy of James Brosher/Indiana University

Indiana University graduate student Di Wu observes a test subject.

Photo courtesy of James Brosher/Indiana University

A recently published study that Indiana University researchers co-authored provides the best evidence yet that movement could be used as a biomarker or a physical measurement that doctors can use to diagnosis. The findings focus on autism.

Diagnosing autism remains dependent on a subjective assessment of a person’s symptoms. IU physics professor Jorge Jose says that can be a problem.

“Because there are many of the same symptoms that can correspond to different conditions,” he says.

Jose is a senior author of a study conducted by IU and Rutgers University researchers. It builds on work they’ve done to record and analyze arm movements as a biomarker for autism.

Di Wu, an IU doctoral student says movement differences wouldn’t be noticed with the naked eye. They used high-speed sensors.

“It actually was a surprise to us that when you zoom in there is so much difference in the single motion’s movement,” says Wu.

The study correctly identified people with autism and could also help assess severity levels of the disorder.

Jose says the research could also lead to the development of an autism application.

“You might actually be able to do these movement tests to tell you if there is any signal there, that something is not quite right,” Jose says.

A movement measurement could also aid in early diagnosis, which is an important factor in autism treatment.

Support independent journalism today. You rely on WFYI to stay informed, and we depend on you to make our work possible. Donate to power our nonprofit reporting today. Give now.

 

Related News

FSSA creates waitlist for Aged and Disabled waiver. Advocates worry it creates barrier to care
What's at stake in the Supreme Court mifepristone case
Psilocybin research fund, pharmacy benefits manager language added to nursing bill